Isabel Leroux-Roels

Isabel is associate professor at  the Department of Diagnostic Sciences of Ghent University and teaches several courses on vaccinology, microbiology and infection control. Her research focuses on the clinical evaluation of safety and immunogenicity of novel vaccines, with a specific emphasis on novel vaccine platforms (e.g. mRNA, viral vectors), vaccine adjuvants and vaccines against respiratory viral infections (influenza, RSV, SARS-CoV-2). Besides many fruitful collaborations with pharmaceutical and biotech companies, Isabel and her team are also actively involved in various international consortium projects such as the Larissa project (Rift Valley fever vaccine; CEPI/Horizon 2020), the Indigo project (effective and affordable influenza vaccines; Horizon 2020) and the recently approved Baxerna project (Mycobacterium tuberculosis vaccine; Horizon-RIA). Isabel is a member of the Vaccination Working Group of the Superior Health Council (Hoge Gezondheidsraad). She has (co-)authored more than 60 papers in international peer-reviewed journals. She is frequently invited as a speaker at (inter)national conferences. Through regular communication in the press, via webinars, etc., Isabel also wants to contribute to informing healthcare providers and the wider public about the importance of vaccination and the safety and efficacy of vaccines.